Dr. Michael Lotem is the head of the Center for Melanoma and Cancer Immunotherapy at Hadassah Medical Center and is at the forefront of innovative research and patient treatment. Key takeaways about him include:
- Leads the Melanoma and Cancer Immunotherapy Center at Hadassah Hospital
- Studying the SLAM family of receptors in the anti-cancer immune response
- Involved with the treatment of melanoma patients with new immunotherapies
- Team includes clinicians and basic and translational researchers
- Immediate access to clinical data and patient-derived tissues